4.1 YTD Expenditure
The CFO reported to the Committee on the YTD October 2022 Expenditure Summary Report as circulated prior to the meeting noting that the draft revenue I&E financial position shows a YTD deficit of €1,149.9m (€874.4m adverse variance on the COVID-19 reported costs and €275.5m adverse variance on core (Non-COVID 19) related costs. She advised that account must also be taken of National Service Plan 2022 funding, which is yet to be drawn down from the Department of Health, of which there is €118.7m yet to be drawn down in December. As the year has progressed, core (non COVID-19) activities increased and the impact of “delayed” care increased demand for core services resulting in core deficits in Acute and Community services.
It was noted that a number of expenditure items such as the Haddington Road Agreement (HRA), building momentum (New Pay Agreement), 2022 DoH Section 39 inflationary fund and Winter Plan 2022 are as yet unfunded for 2022, and the expected costs are circa €565.9m, will fall to be dealt with as part of any Supplementary Estimate for 2022.
The CFO advised the Committee that the Supplementary Estimate for 2022 was approved by the Select Committee on Health the previous day, and the Opening Statement by Minister for Health was noted by the Committee. She advised the Committee that the 2022 Revised Estimates Volume (REV) for Health is scheduled to pass through the Oireachtas no later than the week ending December 09, 2022.
A discussion took place concerning the Supplementary Estimate which does not provide the HSE with the funding initially sought and may present a funding challenge in CORE activities at the end of 2022.
The Chair advised the Committee that the National Service Plan (NSP) 2023 was adopted by the HSE Board and submitted to the Minister on 10 November for approval. It was noted that a significant amount of work has been completed to assess the level of financial issues and risk to be managed within our services in 2023. These were included in the NSP 2023, which is currently being considered by the Minister.
4.2 Health Budget Oversight Group (HBOG) Minutes
4.3 Update on progress with regards to settling reporting requirements to DoH and DPER – verbal update
The draft minutes of the HBOG meeting of 30 June 2022 as circulated were noted.
The Committee noted that the last HBOG meeting was 17 October 2022. The CFO advised that an inperson meeting of HBOG will take place before the end of the year. She advised that she and her team are continuing to liaise with the DoH.
The Committee emphasised the need to ensure that a set of documented and agreed reporting deliverables and arrangements are operating between the HSE, DoH and DPER, and that a plan and timelines should be set, by the end of January 2023, for the coming year. The Committee outlined their strong view that another reporting season without such an agreed and documented approach should not take place.
4.4 Controls Improvement Update
The CFO presented to the Committee an update on the Controls Improvement Programme (ICIP), which was circulated prior to the meeting, the achievement of which is a key element of the CFO’s balanced score card and is reflected on the Corporate Risk Register (CRR13). She advised that they are mid-way into the three-year programme, the purpose of which is to enhance the overall system of internal control within the HSE and to provide additional assurance as to its adequacy ultimately to the EMT, ARC and the Board. Key to this is embedding controls and compliance within HSE culture and continuing to grow awareness across all sectors of the organisation and its staff of the importance of the HSE controls environment and particularly the roles and responsibilities in relation to compliant behaviours.
She provided the Committee with an overview of the ICIP, which incorporates six key work-stream priorities and presented the current project timelines relating to the work-streams and advised that significant progress has been made despite the impact of COVID-19 and the 2021 Cyber Attack.
The Committee welcomed the update and held a discussion concerning the ICIP and some of the workstreams concerning management resources, the delivery of timelines, and further context required in the appendices, to which the CFO provided the Committee with an update and would take on their comments going forward.
4.5 Special Legislative Accounts
The CFO advised the Committee that in addition to the Annual Financial Statements (AFS) the HSE is required to prepare certain accounts under legislation, and present for consideration and recommendation to the Board the following special legislative accounts, which have been audited by the C&AG:
- Patient Private Property Accounts (PPP) as required by Health (repayment scheme) Act 2006.
- Hepatitis C Insurance Scheme Accounts as regulated by the Hepatitis C Compensation Tribunal (amendment) Act, 2006.
- Long Stay Repayments Account as regulated by Section 18 of the Health Act 2006.
- Long Stay Donations fund as regulated by Section 11 of the Health Act 2006.
The Committee noted that they had previously reviewed these drafts at their June and July 2022 meetings, and subsequently these accounts had been audited and there have been no material changes to the accounts. The Committee noted the accounts were submitted within statutory timelines and have been audited without any material changes or amendments, and that all 4 sets of accounts were submitted to the C&AG in line with the statutory requirement.
The Committee considered the special legislative accounts and recommended them to the Board for signing as part of the Boards reserved functions. They also nominated the CEO and Chairman to sign the accounts in line with signature protocols as agreed with the C&AG as set out in the paper.
4.6 PPE Audit – Report & Assurance
The CFO and ND Procurement presented to the Committee with an update on the assurance report on the implementation of the recommendations by KPMG relating to the HSE Personal Protective Equipment (‘PPE’) Phase 2 Report on the management and usage of PPE.
The Committee noted that as at November 2022, KPMG had reviewed the recommendations. They are assured that out of the 17 recommendations that were submitted to HSE management on 14 June 2021, 12 recommendations have been fully implemented. Five recommendations have not been fully implemented due to underlying plans not yet being executed, which were outlined as follows:
- Two of these recommendations were due to be implemented by November 2022. However, they relate to the creation of a new National Emergency Framework which is currently under way and due to be complete by June 2023.
- Two of these recommendations are reliant on the implementation of a new stock management system which is due to be completed by January 2023.
- It was noted that the last recommendation is dependent on the implementation of IFMS, which is a longer term plan due for delivery in phases over the coming years.
The CFO advised the Committee that there are 35 HSE actions that have been agreed as required to support the implementation of the 17 recommendations, and of these, 28 are implemented, 4 are in progress and 3 are late. The items marked as in progress or completed or implemented in the report have been assessed by KPMG, whose assurance has been sought.
The Committee welcomed the update and queried the delay in timelines noting that some recommendations that were due to be implemented have now been given timescales of January 2023 and June 2023.
The Committee requested a level of assurance in relation to Recommendation 2: Sourcing Strategy – Emerging Viral Threat Programme, the completion of which is dependent on funding and on the creation of the new Emergency Management Framework which will include an approved plan for PPE management, and requested that an explanation be sought from EMT outlining the reasoning why that date has moved at a significant rate, before bringing this draft report to the Board.